Lead Sponsor

Société des Produits Nestlé (SPN)

Age

0 - 0 years

Sex

ALL

Healthy Volunteers

Yes

•Healthy newborn infant
•Full-term (\>= 37 weeks gestation)
•Birth weight between \>= 2500 and \< =4500 g
•0-17 days of age on enrolment (day 0 is day of birth)
•Infant's mother has elected not to breastfeed and to exclusively formula-feed infant
•Study explained and written information provided with Caregiver demonstrating understanding of the given information
•Informed consent signed (parent/legal representative)

•Congenital illness or malformation that may affect infant feeding and/or normal growth
•Suspected or known allergy to cow's milk protein
•Significant pre-natal and/or post-natal disease
•Any readmission to hospital (except for hyperbilirubinemia) prior to enrolment
•Infant receiving prescription medication (with exception of topical antibiotics and/or treatment for thrush) or frequent use of over the counter medications except vitamin and mineral supplements
•Infant currently participating in another conflicting clinical study
•Infant's family who in the Investigator's assessment cannot be expected to comply with the protocol

Related studies

NCT05967689 · Advanced or Metastatic NSCLC Harboring Epidermal Growth Factor Receptor (EGFR) Exon 20 Insertion (ex20ins) Mutations

NCT07333521 · Isolated Non-acquired Growth Hormone Deficiency

NCT06948214 · Growth Hormone Deficiency (GHD)

NCT07025031 · Idiopathic Fetal Growth Restriction

NCT07222215 · Estrogen-receptor-positive Breast Cancer, Metastatic Breast Cancer, and more

Growth of Infants Fed an Amino Acid Infant Formula